Delivery Order SPE2DR25D9239-SPE2DR26FFBN7
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,364.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count). This firm fixed-price delivery order, issued on December 9, 2025, with an ultimate completion date of December 10, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. The award is...
- The Defense Logistics Agency awarded a delivery order valued at $12,364.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60 count). The award, issued on November 3, 2025, with an ultimate completion date of November 4, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating the vendor competed in an unrestricted procurement. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $24,676.82 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 20 mg tablets (60-unit package). The contract employs firm fixed-price pricing with an ultimate completion date of December 8, 2025, and was executed without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,396.58 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60 count). This firm fixed-price delivery order, issued on November 24, 2025, with an ultimate completion date of November 25, 2025, was awarded without a set-aside designation, indicating the vendor competed in unrestricted federal procurement. DMS...
- The Defense Logistics Agency awarded a delivery order valued at $12,089.78 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 20 mg tablets (60-count units). This firm fixed-price delivery order, issued on August 6, 2025, is due for completion by August 7, 2025, and carries no set-aside designation. DMS Pharmaceutical Group is performing under its larger Indefinite Delivery Contract with the DLA...
- The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, represents a direct pharmaceutical supply transaction under DMS's existing Indefinite Delivery Contract with the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at $12,146.79 to DMS Pharmaceutical Group Inc. for the supply of Jakafi 5 mg tablets (60-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected as the awardee under a firm fixed-price contract type. The delivery order carries an ultimate completion date of July 11, 2025, with performance to be executed at the vendor's Park Ridge location. No...
- The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a direct pharmaceutical supply transaction under DLA's established procurement framework. The contract carries no...
- The Defense Logistics Agency awarded a delivery order valued at $12,364.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). The award, issued on December 10, 2025, with an ultimate completion date of December 11, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating the vendor's competitive capability in unrestricted...
- The Defense Logistics Agency awarded a delivery order valued at $24,493.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 15 mg tablets (60-count). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of November 19, 2025, and was awarded on November 18, 2025. This award carries no set-aside designation, demonstrating DMS Pharmaceutical Group's...
- SPE2DR25D9239Indefinite Delivery Contract
- SPE2DR25D9239-SPE2DR26FFBN7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $24,493.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 15 mg tablets (60-count units). This firm fixed-price delivery order, awarded on December 2, 2025, with an ultimate completion date of December 3, 2025, was issued without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which carries a $499.9 billion ceiling value and extends through December 31, 2036. DMS Pharmaceutical Group serves as a critical pharmaceutical supplier within the broader $30.3 billion PPV-G GEN V acquisition strategy, positioning the company to fulfill diverse pharmaceutical requirements for Department of Defense healthcare facilities worldwide. The contractor's established track record includes supplying an extensive portfolio of pharmaceuticals ranging from branded and generic prescription medications to biologics, vaccines, and specialty pharmaceutical products. This delivery order for Jakafi, a specialty pharmaceutical used in hematologic malignancies, represents one of numerous orders DLA has issued to DMS Pharmaceutical Group since the primary contract award in November 2025, reflecting the contractor's demonstrated capability to support the recurring and specialized medical supply needs of the military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.5k | 12/1/25 |